Table 1.

Attributes and levels included in the conjoint analysis survey

Scenario attribute	Attribute levels
Way the medicine is given (mode of administration)	• Orally • Skin patch • Injected under skin • Intravenous (IV)
Time in between doses of medicine (dose frequency)	• Daily • Weekly • Monthly • Every 6 months • Yearly
Effectiveness to prevent spine fractures	• 50% reduced risk of spine fracture • 60% reduced risk of spine fracture • 70% reduced risk of spine fracture • 80% reduced risk of spine fracture • 90% reduced risk of spine fracture
Effectiveness to prevent hip fractures	• 0% reduced risk of hip fracture • 20% reduced risk of hip fracture • 40% reduced risk of hip fracture • 60% reduced risk of hip fracture
Risk of non-serious side effects	• No increased risk compared to not taking the medicine • 1% increased risk compared to not taking the medicine • 3% increased risk compared to not taking the medicine • 5% increased risk compared to not taking the medicine
Risk of serious side effects	• No increased risk compared to not taking the medicine • 0.01 out of 1000 people (0.001%) • 1 out of 1000 people (0.1%) • 10 out of 1000 people (1%)

None of the above: I wouldn't choose any of these medicines to treat my osteoporosis.